Immune Therapeutics, Inc. 4
4 · Immune Therapeutics, Inc. · Filed Mar 30, 2016
Insider Transaction Report
Form 4
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
COMMON STOCK
2016-03-10−1,000,000→ 3,817,710 total - Other
COMMON STOCK
2016-03-01+500,000→ 4,817,710 total
Footnotes (4)
- [F1]Shares were issues as consideration for a portion past due salary and expenses.
- [F2]These shares include 2,685,000 held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren; 704,009 held by Griffin Enterprises Group, LLC which is 50% owned by the reporting person and 50% owned and managed by Robert Wilson, the reporting person's son; and 1,428,701 owned by Noreen Griffin individually.
- [F3]These shares were originally issued in consideration for past compensation. The shares should have been cancelled in 2015 but were not cancelled due to technical difficulty obtaining proper documentation from the trustee of the Griffin Family Irrevocable Trust.
- [F4]These shares include 2,685,000 held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren; 704,009 held by Griffin Enterprises Group, LLC which is 50% owned by the reporting person and 50% owned and managed by Robert Wilson, the reporting person's son; and 428,701 owned by Noreen Griffin individually.